Harris & Harris Group, Inc., believes that the study and development of nanotechnology will improve product capabilities and manufacturing productivity. This process has already begun with $147 billion in nanotechnology-enabled products sold in 2007, and an estimate of $3.1 trillion projected to be sold in 2015, according to Lux Research. Nanotechnology can be considered a set of tools that is applicable to a broad set of industries. Hence, the market opportunity for nanotechnology-enabled solutions is large, diverse and growing.
Currently, we have a portfolio of over 25 companies that are developing nanotechnology-enabled products that use the capabilities discussed and the convergence of different areas of science to address needs in a wide range of end markets. As such, we believe we and our shareholders are well positioned to profit from the commercial emergence of nanotechnology.
See a Video on YouTube that Discusses Nanotechnology and
Examples from Harris & Harris Group's Portfolio
The papers below discuss in detail the basis for our thesis of focusing on investing in nanotechnology and Nanotech for HealthcareTM, and Nanotech for ElectronicsTM, respectively: